Haemonetics Corp. (HAE) Misses Q1 EPS by 1c; Affirms FY14 Outlook
Haemonetics Corp. (NYSE: HAE) reported Q1 EPS of $0.46, $0.01 worse ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
